CTN clinical coordinating center - heal studies. POP: 8/14/20-2/13/21
Ended Awarded Last action
- Contract number
- 75N95020F00002
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,938,848
Award facts
- Contract value 100% obligated
- $2,938,847.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$60,969 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Original award | $2,999,817 |
About this award
This is a delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company, to serve as the Clinical Coordinating Center for the HEAL (Helping to End Addiction Long-term) Studies. The award, valued at $2,938,847.78, covers the period from August 14, 2020 to June 15, 2021. The contract is a cost-plus-fixed-fee type and does not have a set-aside designation. As a prime contractor, The Emmes Company LLC provides a range of services to NIDA, including biostatistical analysis, data management, clinical trial coordination, and operational oversight for large-scale research programs, particularly in the areas of substance abuse and addiction. The company has secured numerous prime and sub-contract awards from NIDA and other NIH institutes, demonstrating its extensive expertise in supporting complex biomedical research initiatives.
Quick answers
Who was awarded contract 75N95020F00002?
75N95020F00002 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on August 14, 2020.
How much is contract 75N95020F00002 worth?
The government has obligated $2,938,848 on 75N95020F00002.
Is contract 75N95020F00002 an order under another contract?
Yes. 75N95020F00002 is a delivery order under 75N95020D00012, an indefinite delivery contract.
Was contract 75N95020F00002 competed?
The extent of competition for 75N95020F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award